NeoStrata patent suit
This article was originally published in The Rose Sheet
Executive Summary
Wilmington, Del. federal court rules that Valeant Pharmaceticals willfully infringed two patents held by TriStrata Technology, a subsidiary of NeoStrata, firm announces Nov. 25. Patents cover the use of alpha hydroxy acids "to enhance the therapeutic effect of other substances." Jury verdict permits treble damages, TriStrata notes. Firm also filed a motion for permanent injunction Nov. 25 to prohibit the sale of infringing products, which include Valeant's Glyquin lines. TriStrata still has a lawsuit pending against Valeant related to another product, and also has filed suit against Mary Kay and BeautiControl. Chanel, Clarins and L'Oréal are among other companies that have been the targets of TriStrata patent infringement suits (1"The Rose Sheet" Aug. 30, 1999, p. 6)...